Diltiazem prevents accelerated graft coronary artery disease in heart transplant recipients.
D000206:Actuarial Analysis; D000328:Adult; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D003404:Creatinine / Q000097:blood; D004110:Diltiazem / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000401:mortality / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D015996:Survival Rate; D014019:Tissue Donors
D002317:Cardiovascular Agents; D002784:Cholesterol; D003404:Creatinine; D004110:Diltiazem